Clinical trial
Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating…
NCT00004085 · Garden State Cancer Center at the Center for Molecular Medicine and Immunology, Other · Completed
Key facts
| NCT number | NCT00004085 |
|---|---|
| Title | Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer |
| Official title | Phase I/II Trial of High-Dose Radioimmunotherapy With a 90Y-Humanized MN-14 Anti-Carcinoembryonic Antigen (CEA) Antibody for the Treatment of Stage IV Breast Cancer |
| Lead sponsor | Garden State Cancer Center at the Center for Molecular Medicine and Immunology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Procedure, Radiation |
| Interventions | filgrastim, autologous bone marrow transplantation, peripheral blood stem cell transplantation, yttrium Y 90 monoclonal antibody MN-14 |
| Enrollment | 15 |
| Start date | May 1, 1998 |
| Primary completion | May 1, 2002 |
| First posted | Apr 15, 2004 |
| Last update posted | Jun 22, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: